Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group

S.D. Stoker, M.A. Wildeman, Z. Novalic, R. Fles, V. van der Noort, R. de Bree, W.W. Braunius, G.B. van den Broek, B. Kreike, K.W. Kross, H. Juwana, O. Ramayanti, S.A.W.M. Verkuijlen, J.P. de Boer, A.E. Greijer, J.M. Middeldorp, I.B. Tan

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)

Abstract

This study estimated the value of quantitative measurements of EBV markers in the clinical management of nasopharyngeal carcinoma in a non-endemic area. The aim was to predict prognosis and detect recurrent and residual disease. In 72 patients, EBV DNA load in blood and nasopharyngeal brushes, and IgA VCA-p18 and EBNA1 in plasma were measured at different time points. At diagnosis and post-treatment, a cut-off value was used for detecting disease [positive (PPV) and negative (NPV) predictive value]. The markers were correlated as a continuous variable with tumor stage, disease-free survival (DFS) and overall survival (OS). The Cox hazard ratio model assessed hazard ratios. At diagnosis, the markers were above the COV in 45, 92, 85 and 83 % of the patients, respectively. Post-treatment, DNA load test in blood and brush had the best discriminating power (blood DNA load test: PPV 39 % and NPV 97 %, brush for local disease: PPV 75 % and NPV 99 %). Post-treatment, DNA load in blood was the best predictor for OS and DFS [hazard ratio 3.2 (95 % CI 1.51–3.5) and 2.3 (95 % CI 1.72–5.8)]. Assessing the EBV DNA load in blood has significant prognostic value, although the clinical value is for discussion. The EBV DNA load in the brush might improve early detection of local failures post-treatment.
Original languageEnglish
Pages (from-to)1557-1567
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume273
Issue number6
Early online date1 May 2015
DOIs
Publication statusPublished - Jun 2016

Keywords

  • Diagnostic markers
  • Epstein-Barr virus
  • Nasopharyngeal carcinoma

Cite this